anmelden
FTSE All-Share
5.719,53
PKT
+85,11
PKT
+1,51
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.02.23 | GSK Sell | UBS AG | |
| 01.02.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 01.02.23 | Glencore Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | Unilever Outperform | Credit Suisse Group | |
| 31.01.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | BAT Buy | Jefferies & Company Inc. | |
| 31.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.23 | GSK Hold | Deutsche Bank AG | |
| 31.01.23 | Unilever Buy | Deutsche Bank AG | |
| 30.01.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 30.01.23 | Unilever Buy | Deutsche Bank AG | |
| 30.01.23 | Unilever Buy | Jefferies & Company Inc. | |
| 30.01.23 | Unilever Sector Perform | RBC Capital Markets | |
| 30.01.23 | Unilever Underperform | Bernstein Research | |
| 30.01.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 30.01.23 | Diageo Neutral | UBS AG | |
| 27.01.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 27.01.23 | Diageo Market-Perform | Bernstein Research | |
| 27.01.23 | Diageo Overweight | Barclays Capital | |
| 27.01.23 | Diageo Underperform | RBC Capital Markets | |
| 27.01.23 | Diageo Neutral | UBS AG | |
| 27.01.23 | Diageo Outperform | Credit Suisse Group | |
| 27.01.23 | Diageo Buy | Goldman Sachs Group Inc. | |
| 27.01.23 | Diageo Sell | Deutsche Bank AG | |
| 26.01.23 | Diageo Underperform | RBC Capital Markets | |
| 26.01.23 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 26.01.23 | Diageo Buy | Goldman Sachs Group Inc. | |
| 26.01.23 | Prudential Overweight | JP Morgan Chase & Co. | |
| 26.01.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 25.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 25.01.23 | GSK Equal Weight | Barclays Capital | |
| 23.01.23 | National Grid Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.23 | Vodafone Group Market-Perform | Bernstein Research | |
| 23.01.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 23.01.23 | Vodafone Group Hold | Jefferies & Company Inc. | |
| 20.01.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 19.01.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets |